The Lipid Lowering and Onset of Renal Disease (LORD) Trial: A Randomized Double Blind Placebo Controlled Trial Assessing the Effect of Atorvastatin on the Progression of Kidney Disease
BMC Nephrology - United Kingdom
doi 10.1186/1471-2369-9-4
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 18, 2008
Authors
Publisher
Springer Science and Business Media LLC